Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Asset Writedowns and Impairment (2024 - 2025)

Carlsmed (CARL) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $502000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 1.21% year-over-year to $502000.0, compared with a TTM value of $1.9 million through Dec 2025, changed N/A, and an annual FY2025 reading of $1.8 million, up 33.45% over the prior year.
  • Asset Writedowns and Impairment was $502000.0 for Q4 2025 at Carlsmed, up from $465000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $502000.0 in Q4 2025 and bottomed at $389000.0 in Q3 2024.